rood blauwe elepsis logo Belegger.nl
Uitgebreid zoeken

BioPharma Terug naar discussie overzicht

HEB Memispherx

61 Posts
Pagina: 1 2 3 4 »» | Laatste | Omlaag ↓
  1. [verwijderd] 11 mei 2009 21:01

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    BRIEF-Hemispherx Biopharma announces public equity offerings

    May 11 (Reuters) - Hemispherx Biopharma, Inc : * Announces $18.3 million public equity offerings * Says offering priced at $1.10 per share

    ((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) ((For more news, please click here [HEB.A]))

    Sheff quote:

    Hemispherx Biopharma (HEB): Ampligen (Poly I: Poly C12U) NDA (three month PDUFA decision date delay was announced on 2/18/09 as additional data was submitted by HEB within three months of original decision date). Ampligen is an experimental treatment for chronic fatigue syndrome (which has no FDA-approved treatments) and the drug has an Orphan Drug Status with a PDUFA decision date of 5/25/09.

  5. [verwijderd] 15 mei 2009 20:18

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    quote:

    crackedtooth schreef:

    vooral goed voorbeeld..
    lekker opogelopen... extra hoog open... en daarna nieuws van verwatering
    Toch vandaag ruim 30% in de plus met een flink volume.
  6. welshterrier 5 18 mei 2009 21:08

    • welshterrier 5

      Lid sinds: 23 mrt 2004

      Laatste bezoek: 14 feb 2025

    • Aanbevelingen

      Ontvangen: 291

      Gegeven: 1100

    •    Aantal posts: 20.113

    quote:

    domus muris schreef:

    [quote=crackedtooth]
    vooral goed voorbeeld..
    lekker opogelopen... extra hoog open... en daarna nieuws van verwatering
    [/quote]

    Toch vandaag ruim 30% in de plus met een flink volume.
    nu bijna 2.00!!!!!!!!!!!!!!!!ruim 50 % in de plus
  8. [verwijderd] 18 mei 2009 23:53

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Pump en dump trade
    maar geniet ervan als je trader bent

    HEB inquiry

    Hemispherx Biopharma Comments On Market Activity

    PHILADELPHIA, May 15, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) stated that in view of the unusual market activity in the Company's stock, the NYSE Amex has contacted the Company and requested that the Company issue a public statement indicating as to whether there are any corporate developments which may explain the unusual activity. The Company stated that there have been no material events other than as disclosed in its recent press releases and its filings with the Securities and Exchange Commission that would explain the high volume market activity.

    finance.yahoo.com/news/Hemispherx-Bio...

  10. [verwijderd] 19 mei 2009 09:16

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    quote:

    welshterrier schreef:

    Er komt een eventuele goedkeuring aan voor de 25 e, dus het is geen pump en dump.............
    vlg mij
    wel geklooi, zo een sec message komt er niet iedere dag

    en nogmaals wil niet zeggen dat er geen winst gehaald kan worden erin
  17. welshterrier 5 19 mei 2009 18:18

    • welshterrier 5

      Lid sinds: 23 mrt 2004

      Laatste bezoek: 14 feb 2025

    • Aanbevelingen

      Ontvangen: 291

      Gegeven: 1100

    •    Aantal posts: 20.113

    quote:

    crackedtooth schreef:

    [quote=welshterrier ]
    2,30 al gezien
    [/quote]
    en heb je hem geshort dan?
    ben geen shorter, zou niet weten hoe dat moet
    pfffffffffffffffff
  19. [verwijderd] 23 mei 2009 17:50

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Chronic Fatigue Syndrome Treatment: FDA's Ampligen Decision Imminent
    Friday May 22, 2009

    Will the millions of people with chronic fatigue syndrome (CFS or ME/CFS) finally have an FDA-approved drug treatment? We should know soon, as the long-awaited decision on Ampligen (poly I: poly C12U) is due on or around May 25.

    Ampligen has languished in the "experimental" stage for 30 years. Then, in October 2007, Hemispherex Biopharma Inc. put in a New Drug Application for Ampligen as the first ever FDA approved treatment for ME/CFS. In July 2008, the company responded to questions sent back by the FDA, and the application was officially accepted. The decision was originally due in late February, but the FDA at that time announced it needed 3 more months. Now, it's just a matter of time before we hear yea or nay.

    Ampligen is an immume-system modulator that works by jump-starting your body's natural anti-viral pathway and regulating levels of Rnase L (a substance in your cells that attacks viruses), which can be high in people with ME/CFS. Studies show it's more effective and has far fewer side effects than other drugs in its class. Ampligen has also been studied as a possible treatment for AIDS, avian flu, and certain types of cancer.

    This drug has been available to certain U.S. clinics for several years, and there's a lot of evidence (both clinical and experiential) showing that it works. Some doctors claim they've seen improvement in 80% of people with ME/CFS who take Ampligen, and significant improvement in about 50%. They say a lot of seriously disabled people have even been able to go back to work because of it.

    Side effects are reportedly mild and include flu-like symptoms, dizziness and confusion. (After living with ME/CFS, would you even recognize those as side effects?)

    Here's more info from the manufacturer: Ampligen.

    chronicfatigue.about.com/b/2009/05/22...
  20. [verwijderd] 24 mei 2009 09:43

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Misschien morgen positief nieuws?????????

    Als je de artikelen leest,kan het bijna niet meer mis,maar dat is al vaker gedacht.

    Stukje uit een artikel,je zou toch zeggen dat...................................nah,eerst maar eens zien.

    Vriendelijke groet.

    As reported in BioMedReports this past week, HEB is expecting to hear from the FDA this coming week as to whether Ampligen receives approval as a chronic fatigue syndrome treatment.

    With the "boats loads" of safety data available, Ampligen could quickly be developed for H1N1 flu strain, Piros said. He noted that Hemispherx already has been in discussions with the CDC about its product

    biomedreports.com/articles/most-popul...
61 Posts
Pagina: 1 2 3 4 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.012
AB InBev 2 5.495
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.529
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.588
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.731
Aedifica 3 903
Aegon 3.258 322.687
AFC Ajax 538 7.087
Affimed NV 2 6.289
ageas 5.844 109.887
Agfa-Gevaert 14 2.049
Ahold 3.538 74.330
Air France - KLM 1.025 35.024
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.692
Allfunds Group 4 1.469
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 405
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.819
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.836 242.927
AMG 971 133.205
AMS 3 73
Amsterdam Commodities 305 6.687
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 490
Antonov 22.632 153.605
Aperam 92 14.975
Apollo Alternative Assets 1 17
Apple 5 381
Arcadis 252 8.767
Arcelor Mittal 2.033 320.660
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.295
Aroundtown SA 1 219
Arrowhead Research 5 9.730
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.089
ASML 1.766 106.482
ASR Nederland 21 4.452
ATAI Life Sciences 1 7
Atenor Group 1 485
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.647
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392